Interleukin-17A Antagonist [EPC]

163875 reported adverse events

Drugs of this class: IXEKIZUMAB SECUKINUMAB

These side effects are most commonly reported by patients taking drugs of the Interleukin-17A Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 27393
1 PSORIASIS 22762
2 PAIN 13408
3 ARTHRALGIA 12258
4 PRURITUS 7920
5 FATIGUE 7778
6 PSORIATIC ARTHROPATHY 7288
7 MALAISE 7185
8 RASH 6709
9 INJECTION SITE PAIN 6563
See all common reactions for Interleukin-17A Antagonist [EPC]

Drugs of the Interleukin-17A Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 REBOUND PSORIASIS 381 0.7004
1 LUPUS VULGARIS 150 0.5814
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 144 0.5373
3 DEEP VEIN THROMBOSIS POSTOPERATIVE 289 0.4753
4 RED BLOOD CELL SEDIMENTATION RATE 108 0.4154
5 SWOLLEN JOINT COUNT INCREASED 521 0.4086
6 C-REACTIVE PROTEIN 129 0.3886
7 RHEUMATIC FEVER 656 0.3863
8 FACET JOINT SYNDROME 337 0.3228
9 NAIL PSORIASIS 162 0.3115
See all enriched reactions for Interleukin-17A Antagonist [EPC]